Table 2 Clinical characterization of COPD patients and control subjects in cohort 1.
From: Change in the chondroitin/dermatan structure in distal lung tissue from COPD patients
Non-smokers | Smokers | COPD (GOLD II-III) | COPD (GOLD IV) | |
|---|---|---|---|---|
No | 11 | 11 | 11 | 11 |
Age (range) | 59 (39–86) | 66 (36–81) | 69 (51–77) | 61 (52–69) |
Gender (M/F) | 5/6 | 2/9 | 5/6 | 2/9 |
Pack years | 0 | 28 | 41 | 30 |
Smoking status (Current/ex) | - | 1/10 | 1/10 | 0/11 |
FEV1 (L) | N.D | 2.21 | 1.95 | 0.85 |
FEV1 (%predicted) | N.D | 88.9 | 66.8 | 28.7 |
FEV1/FVC | N.D | 0.73 | 0.57 | 0.39 |
DLCO (%) | N.D | 75 | 69 | 30 |
